Metabolism of lorazepam
- PMID: 10938
- DOI: 10.1093/bja/48.10.1017
Metabolism of lorazepam
Abstract
The metabolism of lorazepam by man and four other species is reviewed. Lorazepam and its metabolites in blood, urine and faeces were identified by thin-layer and gas chromatography and by mass spectrometry. The principal metabolite in man, dog, pig and cat is the glucuronide, but the rat produces other metabolites after small doses of lorazepam, and significant amounts of the glucuronide only after high doses. Since all metabolites, except the glucuronide, occur in small quantities only in man, most studies in man have been confined to an estimation of gree and conjugated lorazepam. Blood concentrations of unconjugated lorazepam peak at 1-4 h, significant concentrations persisting for 24 h and decreasing slowly over the next 24 h. About 95% of a dose of lorazepam was accounted for in urine and faeces over a period of 5 days; 74.5% was excreted in the urine as lorazepam glucuronide and 13.5% as minor metabolites. The excretory half-life was 12 h. The blood concentrations and excretion rates are compatible with the clinical effects of lorazepam.
Similar articles
-
Clinical pharmacokinetics of oxazepam and lorazepam.Clin Pharmacokinet. 1981 Mar-Apr;6(2):89-105. doi: 10.2165/00003088-198106020-00001. Clin Pharmacokinet. 1981. PMID: 6111408 Review.
-
Lorazepam: glucuronide formation in the cat.Drug Metab Dispos. 1975 Mar-Apr;3(2):85-8. Drug Metab Dispos. 1975. PMID: 236163
-
Comparative metabolism of lorazepam in man and four animal species.J Clin Psychiatry. 1978 Oct;39(10 Pt 2):11-5. J Clin Psychiatry. 1978. PMID: 30761
-
Clinical pharmacokinetics of lorazepam. I. Absorption and disposition of oral 14C-lorazepam.Clin Pharmacol Ther. 1976 Sep;20(3):329-41. doi: 10.1002/cpt1976203329. Clin Pharmacol Ther. 1976. PMID: 8232
-
Clinical pharmacokinetics of lorazepam. II. Intramuscular injection.Clin Pharmacol Ther. 1977 Feb;21(2):222-30. doi: 10.1002/cpt1977212222. Clin Pharmacol Ther. 1977. PMID: 13960
Cited by
-
The altered pharmacokinetics and pharmacodynamics of drugs commonly used in critically ill patients.Clin Pharmacokinet. 1988 Jun;14(6):347-73. doi: 10.2165/00003088-198814060-00003. Clin Pharmacokinet. 1988. PMID: 3293870 Review.
-
Pharmacokinetics and pharmacodynamics of sedatives and analgesics in the treatment of agitated critically ill patients.Clin Pharmacokinet. 1997 Dec;33(6):426-53. doi: 10.2165/00003088-199733060-00003. Clin Pharmacokinet. 1997. PMID: 9435992 Review.
-
Clinical pharmacokinetics of cerebrospinal fluid.Clin Pharmacokinet. 1982 Jul-Aug;7(4):312-35. doi: 10.2165/00003088-198207040-00003. Clin Pharmacokinet. 1982. PMID: 6749368 Review.
-
Lorazepam Stimulates IL6 Production and Is Associated with Poor Survival Outcomes in Pancreatic Cancer.Clin Cancer Res. 2023 Sep 15;29(18):3793-3812. doi: 10.1158/1078-0432.CCR-23-0547. Clin Cancer Res. 2023. PMID: 37587561 Free PMC article.
-
Clinical pharmacokinetics of oxazepam and lorazepam.Clin Pharmacokinet. 1981 Mar-Apr;6(2):89-105. doi: 10.2165/00003088-198106020-00001. Clin Pharmacokinet. 1981. PMID: 6111408 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous